Literature DB >> 5924946

The epidemiology of cerebral vascular disease in Canada: an analysis of mortality data.

P C Gordon.   

Abstract

Mortality data for cerebral vascular disease in Canada and its provinces were analysed as an initial approach to the understanding of the epidemiology of this disease. Since 1950, there has been a decline in mortality attributed to vascular lesions of the central nervous system. This decline has been more pronounced in females. Five-year average age-sex-specific rates (1960-64) showed an almost constant proportional increase with age. The highest mortality rates tended to occur in the Eastern Provinces.From 1950 to 1964 there was a 21% decline in mortality due to intracranial hemorrhage and a concomitant 53% decline in mortality attributed to hypertensive disease. Over the same period there was a 24% increase in mortality attributed to cerebral embolism and thrombosis, and an 8% increase in mortality due to arteriosclerotic heart disease. Areal correlations offered only inconsistent support for the hypothesis that these associated trends are due to common etiologic determinants.Evidence presently available does little to clarify to what extent these trends and differences can be attributed to coding, certification and diagnostic practices, and to what extent to changing and differing incidence and prognosis.

Entities:  

Mesh:

Year:  1966        PMID: 5924946      PMCID: PMC1935779     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  15 in total

1.  CEREBRAL HEMORRHAGE IN A POPULATION AFTER A DECADE OF ACTIVE ANTIHYPERTENSIVE TREATMENT.

Authors:  M AURELL; B HOOD
Journal:  Acta Med Scand       Date:  1964-09

2.  RACE DIFFERENCES IN HYPERTENSION MORTALITY TRENDS. DIFFERENTIAL DRUG EXPOSURE AS A THEORY.

Authors:  J HOWARD
Journal:  Milbank Mem Fund Q       Date:  1965-04

3.  Merits of reducing high blood-pressure.

Authors:  A W LEISHMAN
Journal:  Lancet       Date:  1963-06-15       Impact factor: 79.321

4.  Five-year survival of patients with malignant hypertension treated with antihypertensive agents.

Authors:  E R MOHLER; E D FREIS
Journal:  Am Heart J       Date:  1960-09       Impact factor: 4.749

5.  Changes in mortality rates of treated hypertensive patients in a decade.

Authors:  D KINSEY; H S SISE; G P WHITELAW
Journal:  Geriatrics       Date:  1961-08

6.  Results of treatment in malignant hypertension: a seven-year experience in 94 cases.

Authors:  M HARINGTON; P KINCAID-SMITH; J McMICHAEL
Journal:  Br Med J       Date:  1959-11-14

7.  Hypertensive and chronic respiratory disease mortality: confirmation of trends by multiple cause of death data.

Authors:  D E Rueger
Journal:  Public Health Rep       Date:  1966-02       Impact factor: 2.792

Review 8.  Epidemiology of cerebrovascular disease. A review.

Authors:  R A Stallones
Journal:  J Chronic Dis       Date:  1965-08

9.  Hypertensive cardiovascular disease. Effect of antipressor therapy on the course and prognosis.

Authors:  R W Gifford
Journal:  Am J Cardiol       Date:  1966-05       Impact factor: 2.778

10.  CAUSES OF DEATH IN TREATED HYPERTENSIVE PATIENTS: BASED ON 82 DEATHS DURING 1959-61 AMONG AN AVERAGE HYPERTENSIVE POPULATION AT RISK OF 518 PERSONS.

Authors:  H SMIRK; J V HODGE
Journal:  Br Med J       Date:  1963-11-16
View more
  3 in total

1.  The incidence and pattern of cerebrovascular disease in general practice.

Authors:  J Acheson; H W Acheson; J M Tellwright
Journal:  J R Coll Gen Pract       Date:  1968-12

Review 2.  Risk factors in stroke.

Authors:  P Mustacchi
Journal:  West J Med       Date:  1985-08

3.  An epidemiologic study of hypertension in Newfoundland.

Authors:  J G Fodor; E C Abbott; I E Rusted
Journal:  Can Med Assoc J       Date:  1973-06-02       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.